PMID: 2505258Sep 1, 1989Paper

A repertoire of monoclonal antibodies with human heavy chains from transgenic mice

Proceedings of the National Academy of Sciences of the United States of America
M BrüggemannM S Neuberger

Abstract

The introduction of human immunoglobulin gene segments in their unrearranged configuration into the germ line of mice might allow the production of a repertoire of human antibodies. Such transgenic mice could be used for the production of human monoclonal antibodies against human antigens. To test the feasibility of this approach, mice were created that carry a human heavy-chain minilocus comprising unrearranged immunoglobulin variable, diversity, and joining elements linked to a human mu-chain gene. The gene segments of this minilocus are rearranged in a large proportion of cells in thymus and spleen but not in nonlymphoid tissue. Some 4% of the B lymphocytes synthesize human mu chains resulting in a serum titer of about 50 micrograms of transgenic IgM antibody per ml. Hybridomas were established from the transgenic mice that stably secreted several micrograms of antibodies containing human mu heavy chains per milliliter.

References

Nov 1, 1988·Immunology Today·C A Borrebaeck
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M GoodhardtF Rougeon
Mar 24, 1988·Nature·L RiechmannG Winter
Nov 1, 1987·The Journal of Experimental Medicine·M BrüggemannM S Neuberger
Dec 13, 1984·Nature·G L BoulianneM J Shulman
Apr 14, 1983·Nature·S Tonegawa
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S L MorrisonV T Oi
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G Matthyssens, T H Rabbitts

❮ Previous
Next ❯

Citations

Jan 1, 1986·Archives of Dermatological Research·A KappE Schöpf
Jul 30, 2008·Transgenic Research·Alexander Kind, Angelika Schnieke
Oct 12, 1995·Journal of Immunological Methods·K YoshinariY Yamaguchi
May 1, 1995·Immunology Today·G P Cook, I M Tomlinson
Oct 1, 1995·Current Opinion in Biotechnology·A Jakobovits
May 1, 1992·Trends in Cardiovascular Medicine·I M LubinM S Runge
Apr 1, 1997·Current Opinion in Immunology·M S HaydenJ A Ledbetter
Dec 17, 2002·Current Opinion in Biotechnology·Sirid Aimée Kellermann, Larry L Green
Aug 1, 1997·Current Opinion in Biotechnology·M Brüggemann, M J Taussig
May 19, 1998·Trends in Biochemical Sciences·D A SinclairL Guarente
Aug 23, 2002·Immunological Reviews·Herman Waldmann
Jun 13, 1998·Nature Biotechnology·T J VaughanP R Tempest
Jul 1, 1996·Nature Biotechnology·M Neuberger
Sep 10, 2005·Nature Biotechnology·Nils Lonberg
Nov 26, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mats A A Persson
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·N TuaillonJ D Capra
Apr 25, 1994·Nucleic Acids Research·S D WagnerM Brüggemann
Aug 4, 2011·Protein Engineering, Design & Selection : PEDS·Sara PruzinaMichael S Neuberger
May 7, 1998·Microbiology and Immunology·I IshidaK Tomizuka
Jun 6, 2009·Arthritis Research & Therapy·John D Isaacs
Sep 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Frederico Aires da SilvaJoao Goncalves
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Andrew J MurphyGeorge D Yancopoulos
Apr 15, 2008·Expert Opinion on Biological Therapy·Elizabeth Ortiz-SánchezManuel L Penichet
Dec 17, 2015·Viruses·Qingyong NgJimmy Kwang
Nov 1, 2015·Protein Engineering, Design & Selection : PEDS·Alfred W Y LimJulian E Sale
Sep 12, 2015·Transgenic Research·Séverine MénoretIgnacio Anegon
May 28, 2010·MAbs·Roger R Beerli, Christoph Rader
Dec 4, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Marianne BrüggemannRoland Buelow
Jan 1, 1995·International Reviews of Immunology·N Lonberg, D Huszar
Feb 24, 2017·Transplantation·Marianne BrüggemannRoland Buelow
Jan 24, 1991·Nature·G Winter, C Milstein
Mar 6, 1997·Nature·M Neuberger, M Brüggemann
Oct 16, 2002·Nature Biotechnology·Sarah J CumbersMichael S Neuberger
Dec 24, 2019·Journal of Peptide Science : an Official Publication of the European Peptide Society·Benedikt WeberJohannes Buchner
Jan 11, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael J OsbornMarianne Brüggemann
Apr 12, 2016·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Nobuaki TakahashiKazuma Tomizuka
Dec 29, 2009·Médecine sciences : M/S·Michel CognéVirginie Pascal
Jul 13, 2018·BioMed Research International·Urai Chaisri, Wanpen Chaicumpa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.